Objective To investigate the prognostic factors for pregnancy-specific liver disease ( PSLD) , to establish a simple effective model ( NEW mode) using the statistic method, and to investigate the value of Model for End-Stage Liver Disease ( MELD) and NEW model in the prognostic evaluation of PSLD patients. Methods A total of 84 pregnant patients who were admitted to The Third Affiliated Hospital of Guangzhou Medical University due to jaundice and hepatic insufficiency from January 1, 2015 to December 31, 2017 and were diagnosed with acute fatty liver of pregnancy, preeclampsia, or hemolysis, elevated liver enzymes, and low platelets ( HELLP) syndrome were enrolled. According to their prognosis, they were divided into death group with 14 patients and survival group with 70 patients. The MELD model and the NEW model were used for scoring, the sensitivity, specificity, positive predictive value, and negative predictive value of the two models were calculated, and the receiver operating characteristic ( ROC) curve was used to assess the value of these two models in predicting the prognosis of PSLD. The t-test was used for comparison of continuous data between two groups, the chi-square test was used for comparison of categorical data between two groups, and the logistic regression model was used to analyze the prognostic models of PSLD.Results The univariate analysis showed that there were significant differences between the two groups in total bilirubin, direct bilirubin, serum creatinine, international normalized ratio ( INR) , alkaline phosphatase, serum total protein, and albumin ( t =-6. 33, -5. 38, -3. 38, -11. 56, -4. 63, 3. 00, and 2. 19, all P < 0. 05) , among which INR showed the most significant difference and was thus used to establish the NEW model ( R = 5. 812 × INR-11. 3) . Both MELD model and NEW model demonstrated a good predictive value, with an area under the ROC curve of 0. 952 ( 95% confidence interval [CI]: 0. 906-0. 997, P < 0. 05) and 0. 982 ( 95% CI: 0. 958-1. 000, P < 0. 05) , respectively, a sensitivity of 92. 9% and 100%, respectively, and a specificity of 87. 3% and 94. 4%, respectively. Higher scores of MELD model and NEW model were associated with higher fatality rates; the fatality rate was 0 when MELD score was lower than 25, but it increased to 81. 8% when MELD score was above 40; the fatality rate was 0 when R score was lower than-3, but it increased to 84. 6%when R score was above 0. Conclusion Both MELD model and NEW model can predict the prognosis of PSLD patients. The NEW model with reference to INR alone achieves a good value in evaluating prognosis and thus has a good clinical value.
[1] JOSHI D, JAMES A, QUAGLIA A, et al. Liver disease in pregnancy[J]. The Lancet, 2010, 375 (9714) :594-605.
|
[2] CHEN Y, HUANG YJ, GU JH, et al. Early diagnosis and combinative treatment to 11 patients with acute fatty liver of pregnancy[J]. J Prac Obste Gynecol, 2014, 30 (7) :544-547. (in Chinese) 陈宇, 黄亚绢, 顾京红, 等.早期诊断和综合治疗妊娠期急性脂肪肝11例临床分析[J].实用妇产科杂志, 2014, 30 (7) :544-547.
|
[3] WESTBROOK RH, YEOMAN AD, JOSHI D, et al. Outcomes of severe pregnancy-related liver disease:Refining the role of transplantation[J]. Am J Transplant, 2010, 10 (11) :2520-2526.
|
[4] ZARRINPAR A, FARMER DG, GHOBRIAL RM, et al. Liver transplantation for HELLP syndrome[J]. Am Surg, 2007, 73 (10) :1013-1016.
|
[5] HAN PQ, SUN Y. Prognostic models for liver failure and their role in pregnant women with liver failure[J]. J Clin Hepatol, 2018, 34 (3) :635-640. (in Chinese) 韩璞青, 孙嫣.肝衰竭预后评估模型及其在妊娠期肝衰竭中的应用[J].临床肝胆病杂志, 2018, 34 (3) :635-640.
|
[6] KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33 (2) :464-470.
|
[7] HARISH K, NITHA R, HARIKUMAR R, et al. Prospective evaluation of abnormal liver function tests in pregnancy[J]. Trop Gastroenterol, 2005, 26 (4) :188-193.
|
[8] DEVARBHAVI H, KREMERS WK, DIERKHISING R, et al.Pregnancy associated acute liver disease and acute viral hepatitis:differentiation, course and outcome[J]. J Hepatol, 2008, 49 (6) :930-935.
|
[9] YIN YZ, ZHANG PZ. Prognostic assessment of mother and infant in live failure during pregnancy[J/CD]. Chin J Obstet Emerg:Electronic Edition, 2017, 6 (4) :198-202. (in Chinese) 尹玉竹, 张培珍.妊娠期肝衰竭母儿预后的评估[J/CD].中华产科急救电子杂志, 2017, 6 (4) :198-202.
|
[10] FANG L, WU L, ZHANG Y, et al. Multivariate analysis of prognostic factors for fulminant hepatitis in pregnancy[J]. Clin J Clinicians, 2009, 3 (4) :568-573. (in Chinese) .方莉, 伍玲, 张宇, 等.影响妊娠合并重型肝炎预后的临床多因素分析[J].中华临床医师杂志, 2009, 3 (4) :568-573.
|
[11] LI XM, DENG LZ, YANG YB, et al. Clinical significance of serum cholesterol in predicting the prognosis of pregnancy complicating hepatitis gravis[J]. J Sun Yat-Sen Univ:Medical Sciences, 2008, 29 (5) :595-597. (in Chinese) 李小毛, 邓柳枝, 杨越波, 等.血清胆固醇水平在妊娠合并重型肝炎预后判断中的临床意义[J].中山大学学报:医学科学版, 2008, 29 (5) :595-597.
|
[12] WLODZIMIROW KA, ESLAMI S, ABU-HANNA A, et al. A systematic review on prognostic indicators of acute-on-chronic liver failure and their predictive value for mortality[J]. Liver Int, 2013, 33 (1) :40-52.
|
[13] DERUELLE P, COUDOUX E, EGO A, et al. Risk factors for postpartum complications occurring after preeclampsia and HELLP syndrome-a study in 453 consecutive pregnancies[J]. Eur J Obstet Gynecol Reprod Biol, 2006, 125 (1) :59-65.
|
[14] DENG LZ, LI XM, CHEN DJ, et al. The effect of MELD scoring system for predicting the short term prognosis of pregnancy complicating fulminant hepatitis[J]. Clin J Prac Gynecol Obstetr, 2010, 26 (3) :209-212. (in Chinese) 邓柳枝, 李小毛, 陈敦金, 等.终末期肝病模型评分对妊娠合并重型肝炎短期预后的评价作用[J].中国实用妇科与产科杂志, 2010, 26 (3) :209-212.
|
[15] MURALI AR, DEVARBHAVI H, VENKATACHALA PR, et al.Factors that predict 1-month mortality in patients with pregnancy-specific liver disease[J]. Clin Gastroenterol Hepatol, 2014, 12 (1) :109-13.
|